Your browser doesn't support javascript.
loading
A copper-catalyzed asymmetric oxime propargylation enables the synthesis of the gliovirin tetrahydro-1,2-oxazine core.
Cowper, Nicholas G W; Hesse, Matthew J; Chan, Katie M; Reisman, Sarah E.
Afiliação
  • Cowper NGW; The Warren and Katharine Schlinger Laboratory of Chemistry and Chemical Engineering, California Institute of Technology Pasadena CA 91125 USA reisman@caltech.edu.
  • Hesse MJ; The Warren and Katharine Schlinger Laboratory of Chemistry and Chemical Engineering, California Institute of Technology Pasadena CA 91125 USA reisman@caltech.edu.
  • Chan KM; The Warren and Katharine Schlinger Laboratory of Chemistry and Chemical Engineering, California Institute of Technology Pasadena CA 91125 USA reisman@caltech.edu.
  • Reisman SE; The Warren and Katharine Schlinger Laboratory of Chemistry and Chemical Engineering, California Institute of Technology Pasadena CA 91125 USA reisman@caltech.edu.
Chem Sci ; 11(43): 11897-11901, 2020 Oct 15.
Article em En | MEDLINE | ID: mdl-34094417
ABSTRACT
The bicyclic tetrahydro-1,2-oxazine subunit of gliovirin is synthesized through a diastereoselective copper-catalyzed cyclization of an N-hydroxyamino ester. Oxidative elaboration to the fully functionalized bicycle was achieved through a series of mild transformations. Central to this approach was the development of the first catalytic, enantioselective propargylation of an oxime to furnish a key N-hydroyxamino ester intermediate.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article